nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2B—Etoposide—peripheral nervous system neoplasm	0.499	0.624	CbGbCtD
Dexrazoxane—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.13	0.163	CbGbCtD
Dexrazoxane—TOP2A—Etoposide—peripheral nervous system neoplasm	0.101	0.127	CbGbCtD
Dexrazoxane—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.0692	0.0864	CbGbCtD
Dexrazoxane—TOP2B—Teniposide—Etoposide—peripheral nervous system neoplasm	0.002	0.361	CbGdCrCtD
Dexrazoxane—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000863	0.156	CbGdCrCtD
Dexrazoxane—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000513	0.0925	CbGdCrCtD
Dexrazoxane—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000323	0.0584	CbGdCrCtD
Dexrazoxane—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000323	0.0583	CbGdCrCtD
Dexrazoxane—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000323	0.0583	CbGdCrCtD
Dexrazoxane—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000222	0.0401	CbGdCrCtD
Dexrazoxane—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000192	0.000989	CcSEcCtD
Dexrazoxane—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000191	0.000985	CcSEcCtD
Dexrazoxane—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000982	CcSEcCtD
Dexrazoxane—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000191	0.000982	CcSEcCtD
Dexrazoxane—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00019	0.000981	CcSEcCtD
Dexrazoxane—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00019	0.000981	CcSEcCtD
Dexrazoxane—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00019	0.000977	CcSEcCtD
Dexrazoxane—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000188	0.000969	CcSEcCtD
Dexrazoxane—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000188	0.000968	CcSEcCtD
Dexrazoxane—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000187	0.000965	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000957	CcSEcCtD
Dexrazoxane—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000186	0.000956	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000954	CcSEcCtD
Dexrazoxane—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000185	0.00095	CcSEcCtD
Dexrazoxane—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000184	0.000949	CcSEcCtD
Dexrazoxane—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000184	0.000949	CcSEcCtD
Dexrazoxane—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000939	CcSEcCtD
Dexrazoxane—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000937	CcSEcCtD
Dexrazoxane—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000182	0.000936	CcSEcCtD
Dexrazoxane—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000181	0.000934	CcSEcCtD
Dexrazoxane—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000934	CcSEcCtD
Dexrazoxane—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000181	0.000934	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000181	0.000932	CcSEcCtD
Dexrazoxane—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00018	0.000929	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00018	0.000927	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00018	0.000927	CcSEcCtD
Dexrazoxane—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000179	0.000924	CcSEcCtD
Dexrazoxane—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000179	0.000923	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000179	0.000922	CcSEcCtD
Dexrazoxane—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000178	0.000917	CcSEcCtD
Dexrazoxane—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000178	0.000917	CcSEcCtD
Dexrazoxane—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000178	0.000916	CcSEcCtD
Dexrazoxane—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.000913	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.000907	CcSEcCtD
Dexrazoxane—Malaise—Etoposide—peripheral nervous system neoplasm	0.000176	0.000906	CcSEcCtD
Dexrazoxane—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.000906	CcSEcCtD
Dexrazoxane—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000175	0.000899	CcSEcCtD
Dexrazoxane—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.000898	CcSEcCtD
Dexrazoxane—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.000898	CcSEcCtD
Dexrazoxane—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000174	0.000896	CcSEcCtD
Dexrazoxane—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000174	0.000896	CcSEcCtD
Dexrazoxane—Infection—Cisplatin—peripheral nervous system neoplasm	0.000173	0.000889	CcSEcCtD
Dexrazoxane—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000173	0.000889	CcSEcCtD
Dexrazoxane—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000172	0.000883	CcSEcCtD
Dexrazoxane—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000171	0.000881	CcSEcCtD
Dexrazoxane—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000171	0.000881	CcSEcCtD
Dexrazoxane—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000171	0.00088	CcSEcCtD
Dexrazoxane—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00017	0.000878	CcSEcCtD
Dexrazoxane—Cough—Etoposide—peripheral nervous system neoplasm	0.00017	0.000877	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00017	0.000876	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000876	CcSEcCtD
Dexrazoxane—Headache—Topotecan—peripheral nervous system neoplasm	0.00017	0.000875	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00017	0.000874	CcSEcCtD
Dexrazoxane—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000169	0.000873	CcSEcCtD
Dexrazoxane—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000169	0.00087	CcSEcCtD
Dexrazoxane—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000169	0.00087	CcSEcCtD
Dexrazoxane—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000869	CcSEcCtD
Dexrazoxane—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000169	0.000868	CcSEcCtD
Dexrazoxane—Headache—Tretinoin—peripheral nervous system neoplasm	0.000169	0.000868	CcSEcCtD
Dexrazoxane—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000169	0.0304	CbGdCrCtD
Dexrazoxane—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.000169	0.0304	CbGdCrCtD
Dexrazoxane—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.000169	0.0304	CbGdCrCtD
Dexrazoxane—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.000866	CcSEcCtD
Dexrazoxane—Pain—Vincristine—peripheral nervous system neoplasm	0.000168	0.000866	CcSEcCtD
Dexrazoxane—Constipation—Vincristine—peripheral nervous system neoplasm	0.000168	0.000866	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.000859	CcSEcCtD
Dexrazoxane—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000166	0.000853	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000165	0.00085	CcSEcCtD
Dexrazoxane—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000164	0.000845	CcSEcCtD
Dexrazoxane—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000845	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000842	CcSEcCtD
Dexrazoxane—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.000835	CcSEcCtD
Dexrazoxane—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000831	CcSEcCtD
Dexrazoxane—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000831	CcSEcCtD
Dexrazoxane—Nausea—Topotecan—peripheral nervous system neoplasm	0.000161	0.00083	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000161	0.000828	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000825	CcSEcCtD
Dexrazoxane—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00016	0.000823	CcSEcCtD
Dexrazoxane—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00016	0.000823	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000816	CcSEcCtD
Dexrazoxane—Infection—Etoposide—peripheral nervous system neoplasm	0.000158	0.000815	CcSEcCtD
Dexrazoxane—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000158	0.000813	CcSEcCtD
Dexrazoxane—Nausea—Melphalan—peripheral nervous system neoplasm	0.000158	0.000813	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000811	CcSEcCtD
Dexrazoxane—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000808	CcSEcCtD
Dexrazoxane—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.0281	CbGdCrCtD
Dexrazoxane—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.0281	CbGdCrCtD
Dexrazoxane—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.0281	CbGdCrCtD
Dexrazoxane—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000156	0.000803	CcSEcCtD
Dexrazoxane—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000155	0.0008	CcSEcCtD
Dexrazoxane—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000155	0.0008	CcSEcCtD
Dexrazoxane—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000798	CcSEcCtD
Dexrazoxane—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000155	0.000797	CcSEcCtD
Dexrazoxane—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000782	CcSEcCtD
Dexrazoxane—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000152	0.000782	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000779	CcSEcCtD
Dexrazoxane—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000778	CcSEcCtD
Dexrazoxane—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000151	0.000775	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00015	0.000773	CcSEcCtD
Dexrazoxane—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000768	CcSEcCtD
Dexrazoxane—Pain—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000766	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000763	CcSEcCtD
Dexrazoxane—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000756	CcSEcCtD
Dexrazoxane—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000754	CcSEcCtD
Dexrazoxane—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000748	CcSEcCtD
Dexrazoxane—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000144	0.000743	CcSEcCtD
Dexrazoxane—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000143	0.000738	CcSEcCtD
Dexrazoxane—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000731	CcSEcCtD
Dexrazoxane—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000142	0.000731	CcSEcCtD
Dexrazoxane—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000142	0.000729	CcSEcCtD
Dexrazoxane—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000141	0.000726	CcSEcCtD
Dexrazoxane—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000725	CcSEcCtD
Dexrazoxane—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000721	CcSEcCtD
Dexrazoxane—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000721	CcSEcCtD
Dexrazoxane—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00014	0.00072	CcSEcCtD
Dexrazoxane—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.000719	CcSEcCtD
Dexrazoxane—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000138	0.000713	CcSEcCtD
Dexrazoxane—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00071	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000137	0.000708	CcSEcCtD
Dexrazoxane—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000708	CcSEcCtD
Dexrazoxane—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000137	0.000707	CcSEcCtD
Dexrazoxane—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000703	CcSEcCtD
Dexrazoxane—Pain—Etoposide—peripheral nervous system neoplasm	0.000136	0.000701	CcSEcCtD
Dexrazoxane—Constipation—Etoposide—peripheral nervous system neoplasm	0.000136	0.000701	CcSEcCtD
Dexrazoxane—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000699	CcSEcCtD
Dexrazoxane—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000135	0.000695	CcSEcCtD
Dexrazoxane—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000135	0.000693	CcSEcCtD
Dexrazoxane—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000677	CcSEcCtD
Dexrazoxane—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000131	0.000676	CcSEcCtD
Dexrazoxane—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000131	0.000673	CcSEcCtD
Dexrazoxane—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000673	CcSEcCtD
Dexrazoxane—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000671	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00013	0.000671	CcSEcCtD
Dexrazoxane—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00013	0.000669	CcSEcCtD
Dexrazoxane—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.000668	CcSEcCtD
Dexrazoxane—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000667	CcSEcCtD
Dexrazoxane—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000667	CcSEcCtD
Dexrazoxane—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000128	0.000658	CcSEcCtD
Dexrazoxane—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000127	0.000652	CcSEcCtD
Dexrazoxane—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00065	CcSEcCtD
Dexrazoxane—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00065	CcSEcCtD
Dexrazoxane—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000126	0.000648	CcSEcCtD
Dexrazoxane—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000126	0.000648	CcSEcCtD
Dexrazoxane—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000647	CcSEcCtD
Dexrazoxane—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000125	0.000644	CcSEcCtD
Dexrazoxane—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000642	CcSEcCtD
Dexrazoxane—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000637	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000636	CcSEcCtD
Dexrazoxane—Headache—Vincristine—peripheral nervous system neoplasm	0.000123	0.000634	CcSEcCtD
Dexrazoxane—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.000624	CcSEcCtD
Dexrazoxane—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000622	CcSEcCtD
Dexrazoxane—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000612	CcSEcCtD
Dexrazoxane—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000602	CcSEcCtD
Dexrazoxane—Nausea—Vincristine—peripheral nervous system neoplasm	0.000117	0.000601	CcSEcCtD
Dexrazoxane—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000601	CcSEcCtD
Dexrazoxane—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000599	CcSEcCtD
Dexrazoxane—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00059	CcSEcCtD
Dexrazoxane—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000114	0.000588	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000588	CcSEcCtD
Dexrazoxane—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000587	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000583	CcSEcCtD
Dexrazoxane—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000113	0.00058	CcSEcCtD
Dexrazoxane—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000572	CcSEcCtD
Dexrazoxane—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000569	CcSEcCtD
Dexrazoxane—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000567	CcSEcCtD
Dexrazoxane—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000563	CcSEcCtD
Dexrazoxane—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000563	CcSEcCtD
Dexrazoxane—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000109	0.000561	CcSEcCtD
Dexrazoxane—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000556	CcSEcCtD
Dexrazoxane—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000543	CcSEcCtD
Dexrazoxane—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000105	0.000542	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.00054	CcSEcCtD
Dexrazoxane—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000103	0.000532	CcSEcCtD
Dexrazoxane—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000529	CcSEcCtD
Dexrazoxane—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000525	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000523	CcSEcCtD
Dexrazoxane—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000101	0.000521	CcSEcCtD
Dexrazoxane—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000521	CcSEcCtD
Dexrazoxane—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000521	CcSEcCtD
Dexrazoxane—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000521	CcSEcCtD
Dexrazoxane—Headache—Etoposide—peripheral nervous system neoplasm	9.98e-05	0.000514	CcSEcCtD
Dexrazoxane—Malaise—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000508	CcSEcCtD
Dexrazoxane—Syncope—Epirubicin—peripheral nervous system neoplasm	9.81e-05	0.000505	CcSEcCtD
Dexrazoxane—Leukopenia—Epirubicin—peripheral nervous system neoplasm	9.79e-05	0.000504	CcSEcCtD
Dexrazoxane—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	9.61e-05	0.000495	CcSEcCtD
Dexrazoxane—Cough—Epirubicin—peripheral nervous system neoplasm	9.54e-05	0.000492	CcSEcCtD
Dexrazoxane—Nausea—Etoposide—peripheral nervous system neoplasm	9.46e-05	0.000487	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.000484	CcSEcCtD
Dexrazoxane—Anaemia—Doxorubicin—peripheral nervous system neoplasm	9.35e-05	0.000482	CcSEcCtD
Dexrazoxane—Myalgia—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.00048	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	9.25e-05	0.000476	CcSEcCtD
Dexrazoxane—Discomfort—Epirubicin—peripheral nervous system neoplasm	9.2e-05	0.000474	CcSEcCtD
Dexrazoxane—Malaise—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.00047	CcSEcCtD
Dexrazoxane—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.11e-05	0.000469	CcSEcCtD
Dexrazoxane—Syncope—Doxorubicin—peripheral nervous system neoplasm	9.08e-05	0.000467	CcSEcCtD
Dexrazoxane—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	9.06e-05	0.000467	CcSEcCtD
Dexrazoxane—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	8.9e-05	0.000458	CcSEcCtD
Dexrazoxane—Infection—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000457	CcSEcCtD
Dexrazoxane—Cough—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000455	CcSEcCtD
Dexrazoxane—Shock—Epirubicin—peripheral nervous system neoplasm	8.78e-05	0.000452	CcSEcCtD
Dexrazoxane—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.000451	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	8.74e-05	0.00045	CcSEcCtD
Dexrazoxane—Skin disorder—Epirubicin—peripheral nervous system neoplasm	8.67e-05	0.000447	CcSEcCtD
Dexrazoxane—Myalgia—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000444	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000441	CcSEcCtD
Dexrazoxane—Discomfort—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.000438	CcSEcCtD
Dexrazoxane—Anorexia—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000438	CcSEcCtD
Dexrazoxane—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.43e-05	0.000434	CcSEcCtD
Dexrazoxane—Infection—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000423	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000419	CcSEcCtD
Dexrazoxane—Shock—Doxorubicin—peripheral nervous system neoplasm	8.13e-05	0.000418	CcSEcCtD
Dexrazoxane—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000417	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	8.09e-05	0.000416	CcSEcCtD
Dexrazoxane—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000416	CcSEcCtD
Dexrazoxane—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.02e-05	0.000413	CcSEcCtD
Dexrazoxane—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.00041	CcSEcCtD
Dexrazoxane—Somnolence—Epirubicin—peripheral nervous system neoplasm	7.94e-05	0.000409	CcSEcCtD
Dexrazoxane—Anorexia—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000405	CcSEcCtD
Dexrazoxane—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.0004	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000397	CcSEcCtD
Dexrazoxane—Fatigue—Epirubicin—peripheral nervous system neoplasm	7.7e-05	0.000396	CcSEcCtD
Dexrazoxane—Pain—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000393	CcSEcCtD
Dexrazoxane—Constipation—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000393	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000388	CcSEcCtD
Dexrazoxane—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000385	CcSEcCtD
Dexrazoxane—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000379	CcSEcCtD
Dexrazoxane—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000379	CcSEcCtD
Dexrazoxane—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	0.000378	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000376	CcSEcCtD
Dexrazoxane—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.00037	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000367	CcSEcCtD
Dexrazoxane—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.12e-05	0.000367	CcSEcCtD
Dexrazoxane—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000365	CcSEcCtD
Dexrazoxane—Pain—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000364	CcSEcCtD
Dexrazoxane—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000364	CcSEcCtD
Dexrazoxane—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.06e-05	0.000363	CcSEcCtD
Dexrazoxane—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.06e-05	0.000363	CcSEcCtD
Dexrazoxane—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000351	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.000348	CcSEcCtD
Dexrazoxane—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000338	CcSEcCtD
Dexrazoxane—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000336	CcSEcCtD
Dexrazoxane—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000336	CcSEcCtD
Dexrazoxane—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.00033	CcSEcCtD
Dexrazoxane—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.000325	CcSEcCtD
Dexrazoxane—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.000315	CcSEcCtD
Dexrazoxane—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000305	CcSEcCtD
Dexrazoxane—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.9e-05	0.000304	CcSEcCtD
Dexrazoxane—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000301	CcSEcCtD
Dexrazoxane—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000292	CcSEcCtD
Dexrazoxane—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.65e-05	0.000291	CcSEcCtD
Dexrazoxane—Headache—Epirubicin—peripheral nervous system neoplasm	5.59e-05	0.000288	CcSEcCtD
Dexrazoxane—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000281	CcSEcCtD
Dexrazoxane—Nausea—Epirubicin—peripheral nervous system neoplasm	5.3e-05	0.000273	CcSEcCtD
Dexrazoxane—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.00027	CcSEcCtD
Dexrazoxane—Headache—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000266	CcSEcCtD
Dexrazoxane—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.91e-05	0.000253	CcSEcCtD
